Skip to main content
Top
Published in: Journal of Nephrology 5/2023

23-12-2022 | Epispadia | Original Article

Preoperative and postoperative urinary NGAL levels in children with bladder exstrophy

Authors: Alisha Gupta, Minu Bajpai, Sachit Anand, Abid Ali

Published in: Journal of Nephrology | Issue 5/2023

Login to get access

Abstract

Background

Urinary NGAL (neutrophil gelatinase-associated lipocalin) levels have been shown to predict renal damage in various medical conditions. The present study was conducted to study the role of urinary NGAL levels in children with bladder exstrophy–epispadias complex post single-stage total reconstruction (SSTR) as markers of early renal function reduction.

Methods

Urine samples were collected from children with bladder exstrophy before SSTR (Group A, n = 11), 5 years post SSTR (Group B, n = 40) and controls (Group C, n = 41) and stored at − 20 °C. NGAL levels were estimated using double antibody sandwich ELISA.

Results

Mean NGAL levels in Groups A, B and C were 1.39, 34.24 and 2.58 ng/ml, respectively. Mean NGAL levels among Group B subjects with glomerular filtration rate (GFR) ≥ 80 ml/min/1.73 m2 body surface area (BSA) was 29.8 ng/ml, while it was 31.74 ng/ml in those with GFR < 80 ml/min. Urine samples were also evaluated 6 months post SSTR. Mean NGAL at 6 months was 6.76 ng/ml, while at 12 months it was 30.3 ng/ml, remaining > 30 ng/ml at 18 and 24 months. Dimercaptosuccinic acid (DMSA) scans did not show any scarring, and GFR on diethylenetriamine pentaacetate (DTPA) scans remained stable.

Conclusions

Increasing levels of urinary NGAL following bladder-exstrophy and epispadias complex repair suggest that NGAL detects the earliest signs of renal damage even before any deterioration is observed in DMSA and/or DTPA-GFR scans. Further studies with an adequate sample size and periodic measurement of NGAL need to be performed before any definitive conclusion can be drawn.

Graphical Abstract

Literature
2.
go back to reference Gearhart JP, Jeffs RD (2003) Exstrophy of the bladder, epispadias and other bladder anomalies. In: Walsh PC, Retik AB, Stamey TA, Vaughn ED (eds) Campbell’s urology. W.B. Saunders, Philadelphia, pp 1772–1812 Gearhart JP, Jeffs RD (2003) Exstrophy of the bladder, epispadias and other bladder anomalies. In: Walsh PC, Retik AB, Stamey TA, Vaughn ED (eds) Campbell’s urology. W.B. Saunders, Philadelphia, pp 1772–1812
Metadata
Title
Preoperative and postoperative urinary NGAL levels in children with bladder exstrophy
Authors
Alisha Gupta
Minu Bajpai
Sachit Anand
Abid Ali
Publication date
23-12-2022
Publisher
Springer International Publishing
Keyword
Epispadia
Published in
Journal of Nephrology / Issue 5/2023
Print ISSN: 1121-8428
Electronic ISSN: 1724-6059
DOI
https://doi.org/10.1007/s40620-022-01548-x

Other articles of this Issue 5/2023

Journal of Nephrology 5/2023 Go to the issue

Lessons for the Clinical Nephrologist

Acute kidney injury following methotrexate treatment

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine